nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

21.11.2019 | Letter to the Editor

¹⁸F-Fluoride (¹⁸F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!

verfasst von: Giorgio Treglia, Luca Giovanella

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Duarte PS. Letter to the Editor: ¹⁸F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2019:1–2. https://doi.org/10.1007/s00259-019-04556-5.

Giovanella L, Treglia G, Iakovou I, Mihailovic J, Verburg FA, Luster M. EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04458-6.CrossRef

Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21(4):125–7.CrossRef

Bassler D, Mueller KF, Briel M, Kleijnen J, Marusic A, Wager E, et al. Bias in dissemination of clinical research findings: structured OPEN framework of what, who and why, based on literature review and expert consensus. BMJ Open. 2016;6(1):e010024.CrossRef

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610.CrossRef

Treglia G, Aktolun C, Chiti A, Frangos S, Giovanella L, Hoffmann M, et al. Luster M; EANM and the EANM Thyroid Committee. The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the “evidence-based” refusal to endorse them by EANM due to the “not evidence-based” marginalization of the role of nuclear medicine. Eur J Nucl Med Mol Imaging. 2016;43(8):1486–90.CrossRef

Titel: 18F-Fluoride (18F-NaF) PET/CT in medullary thyroid carcinoma: far from evidence, far from guidelines!
verfasst von: Giorgio Treglia
Luca Giovanella
Publikationsdatum: 21.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-019-04563-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Letter to the Editor: 18F-NaF not cited in the EANM practice guideline for PET/CT imaging in medullary thyroid carcinoma

Variations in radioiodine ablation: decision-making after total thyroidectomy

The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia

The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients

Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients

Radiology and nuclear medicine: advancing together in the era of precision medicine